Dana-Farber Cancer Institute Intellectual Property Legal Assistant Salaries in Providence, RI
The average Dana-Farber Cancer Institute Intellectual Property Legal Assistant in Providence, RI earns an estimated $79,243 annually. Dana-Farber Cancer Institute's Intellectual Property Legal Assistant compensation is $19,080 more than the US average for a Intellectual Property Legal Assistant.
In Providence, RI, The Legal Department at Dana-Farber Cancer Institute earns $4,757 more on average than the Product Department.
Last updated 9 months ago.
- $79,243
- avg. base
Intellectual Property Legal Assistant Salaries at Dana-Farber Cancer Institute
In Providence, RI, Intellectual Property Legal Assistants earn $16,465 more than Paralegals, and $81,261 less than General Counsels.
Compensation at Dana-Farber Cancer Institute by Department
In Providence, RI, The Legal Department averages $4,757 more than the Product Department, and $46,317 less than the Enterprise Risk Department
Intellectual Property Legal Assistant Compensation by Gender (All Companies)
The average female Intellectual Property Legal Assistant at companies similar size to Dana-Farber Cancer Institute reported making $70,170, while the average male Intellectual Property Legal Assistant at similar sized companies reported making $144,000.
Intellectual Property Legal Assistant Compensation by Ethnicity (All Companies)
The average Caucasian Intellectual Property Legal Assistant at companies similar size to Dana-Farber Cancer Institute reported making $82,826, while the average Hispanic or Latino Intellectual Property Legal Assistant at similar sized companies reported making $60,000.
How Intellectual Property Legal Assistants at Dana-Farber Cancer Institute Rate Their Compensation
The majority of Intellectual Property Legal Assistants at Dana-Farber Cancer Institute believe they're compensated fairly. The vast majority (78%) of Intellectual Property Legal Assistants at Dana-Farber Cancer Institute are satisfied with their benefits. See more compensation ratings at Dana-Farber Cancer Institute
